ABCB4 and cholestasis: ALP, a biochemical marker of cholestasis, was reduced in Mdr2-/- mice by cilofexor therapy (Fig. 1A), while serum levels of liver transaminases ALT and AST, as well as BAs, remained unchanged (Fig. S2).